FDA Flooded With Complaints as Hip Implant Injuries Surge
Posted By The Carlson Law Firm || 31-Aug-2011
The U.S. federal government has continued to see a marked rise in consumers complaining of failed Depuy hip implants, highlighting increased focus on faulty manufacturing and design practices of the medical device.
Johnson & Johnson Depuy Orthopaedics, one of 21 metal-on-metal hip implant manufacturers, issued a voluntary recall in Aug. 2010. They had already begun notifying health care professionals about hip implant failures in March 2010.
New FDA Studies Focus on Implant Failure
Since January 2011, the Food and Drug Administration (FDA) has reported as many as 5,000 new complaints, filed by consumers struggling with the metal hip implants. Although problems with the device have been reported from the time of its implementation, the FDA notes that complaints since the beginning of 2011 have exceeded the total number recorded in the past four years combined.
Reports of failure or complications are stemming from new hip implants as well as replacements that swapped out faulty devices, previously reported as defective. While issues with the hip implant continue to mount, the defective medical products are on track to become one of the most costly medical implant recalls of the decade. The New York Times reports that more than 7,500 total complaints have been filed regarding the hip implant failure.
Side Effects and Complications
Side effects and issues suffered by patients fitted with the defective medical device include; hip, groin, leg and lower back pain, awkward sensations when standing, walking or moving the lower body, negative impact on activity levels due to pain and/or crunching or clicking sounds coming from the implant site. Rashes and inflammation have also been noted.
Despite efforts by surgeons to opt for plastic-metal comprised implant devices, in contrast with previous metal-metal options, the FDA recently called for studies to be conducted regarding additional testing of metal device failures and negative consumer experiences.